Our senior management team has over 50 years combined experience in research and development of drugs for CNS indications. We are experienced in all aspects of drug development.
- Dr Mark Watling – Medical Advisor
- Dr Deborah Scholey – Regulatory Affairs
- Dr Belinda Pierce – Quality Assurance